Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $103.7700 (0.25%) ($102.8600 - $105.5000) on Tue. Nov. 19, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.75% (three month average) | RSI | 43 | Latest Price | $103.7700(0.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.9% a day on average for past five trading days. | Weekly Trend | LGND declines -2.2% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(55%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.375% in a week (0% probabilities). VIXM(-33%) VXX(-20%) TLT(-14%) UUP(-5%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.375% (StdDev 2.75%) | Hourly BBV | 0 () | Intraday Trend | -0.5% | | | |
|
1 - 5 Day Possible Target | $100.38(-3.27%) | Resistance Level | $108.42 | 5 Day Moving Average | $105.98(-2.09%) | 10 Day Moving Average | $106(-2.1%) | 20 Day Moving Average | $108.42(-4.29%) | To recent high | -8.6% | To recent low | 20.3% | Market Cap | $1.668b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |